Previous Article | Next Article ![]()
CRUK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
* To whom correspondence should be addressed. Email:
j.c.steele{at}bham.ac.uk.
We have evaluated a neutralising antibody assay which uses HPV16 and HPV18 pseudovirions carrying a secretory alkaline phosphatase reporter gene, and which can potentially measure functionally-relevant HPV type-specific neutralising antibodies. The reproducibility of the assay was excellent; for HPV16, the intra- and inter-assay kappa values were 0.95 and 0.90, respectively; and for HPV18, the corresponding values were 0.90 and 0.90. This assay was used to describe the kinetics of the neutralising antibody response in a cohort of 42 young women who were recruited soon after first intercourse, and who first tested positive for HPV16 DNA, or HPV18 DNA, or both, during follow-up. Most women seroconverted following the first detection of type-specific HPV DNA, and remained seropositive until the end of follow-up. Our findings are broadly consistent with those of two other cohort studies which have measured the serological response following an incident infection using the technically simpler virus like particle-based ELISA.
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Measurement of the humoral immune response following an incident HPV16 or HPV18 infection in young women using a pseudovirion-based neutralising antibody assay
![]()
Abstract
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |